Research questions use of sleep meds for patients with apnea - SpiritIndia

Research questions use of sleep meds for patients with apneaSpiritIndia, India - 12 minutes agoPatients taking zolpidem or placebo were instructed to take one pill each night, 30 minutes prior to bedtime for the first 14 days of treatment. …

Read full story

Comments

Actelion's orexin drug shows promise for insomnia sufferers - Pharma Times (subscription)

Actelion's orexin drug shows promise for insomnia sufferersPharma Times (subscription), UK - 12 hours agoThe insomnia market is still dominated by Sanofi-Aventis’ Stilnox/Ambien (zolpidem) and, since the second quarter, generic versions of the latter. …

Read full story

Comments

Management of insomnia: treatments and mechanismsi - British Journal of Psychiatry (subscription)

Management of insomnia: treatments and mechanismsiBritish Journal of Psychiatry (subscription), UK - 10 hours agoBenzodiazepines and the Z-drugs (zolpidem and zopiclone, and to a lesser extent zaleplon) are the most commonly used hypnotics which act on the …

Read full story

Comments

Test cheer for ReGen - Growthcompany.co.uk (subscription)

Test cheer for ReGenGrowthcompany.co.uk (subscription), UK - Aug 23, 2007Bombed-out biotech venture ReGen Therapeutics has received encouraging clinical trial results for its Zolpidem insomnia drug. Since Zolpidem was first …

Read full story

Comments

UK small caps stay sharply higher at midday - Hemscott

UK small caps stay sharply higher at middayHemscott, UK - Aug 23, 2007Gains were also seen in ReGen Therapeutics, 0.175 pence stronger at 0.95, on news its clinical study to explore the effects of zolpidem in people who have …

Read full story

Comments

Small cap round-up: ReGen, Genetix, Sarantel - ShareCast

Small cap round-up: ReGen, Genetix, SarantelShareCast, UK - Aug 23, 2007LONDON (SHARECAST) - Shares in ReGen Therapeutics were higher after a small study exploring the effects of zolpidem in people who have suffered brain damage …

Read full story

Comments

UK small caps close sharply higher; Wham Energy biggest gainer on … - CNNMoney.com

UK small caps close sharply higher; Wham Energy biggest gainer on …CNNMoney.com - Aug 23, 2007Also gaining was ReGen Therapeutics, 0.15 pence firmer at 0.925, on news its clinical study to explore the effects of zolpidem in people who have suffered …

Read full story

Comments

Photosensitive medicines listed - Biloxi Sun Herald

Photosensitive medicines listedBiloxi Sun Herald,  USA - 2 hours agoAnti-anxiety/sleeping agents: alprazolam (Xanax); chlordiazepoxide (Librium); eszopiclone (Lunesta); zaleplon (Sonata); zolpidem (Ambien). …

Read full story

Comments

ReGen Therapeutics says study confirms new - Hemscott

ReGen Therapeutics says study confirms newHemscott, UK - 3 hours agoLONDON (Thomson Financial) - ReGen Therapeutics PLC said the clinical study to explore the effects of zolpidem in people who have suffered brain damage …

Read full story

Comments

Review Addresses Pharmacologic Treatments of Insomnia - Medscape (subscription)

Review Addresses Pharmacologic Treatments of InsomniaMedscape (subscription) - Aug 17, 2007Examples of the nonbenzodiazepines include eszopiclone, zaleplon, and zolpidem (level of evidence, B). Although little available evidence supports combining …

Read full story

Comments

· « Previous entries